A citation-based method for searching scientific literature

Wanrong Yi, Mei-Juan Tu, Zhenzhen Liu, Chao Zhang, Neelu Batra, Ai-Xi Yu, Ai-Ming Yu. Acta Pharm Sin B 2020
Times Cited: 34







List of co-cited articles
283 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy.
Pui Yan Ho, Zhijian Duan, Neelu Batra, Joseph L Jilek, Mei-Juan Tu, Jing-Xin Qiu, Zihua Hu, Theodore Wun, Primo N Lara, Ralph W DeVere White,[...]. J Pharmacol Exp Ther 2018
34
26

Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models.
Mei-Juan Tu, Pui Yan Ho, Qian-Yu Zhang, Chao Jian, Jing-Xin Qiu, Edward J Kim, Richard J Bold, Frank J Gonzalez, Huichang Bi, Ai-Ming Yu. Cancer Lett 2019
34
23



Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal Immunogenicity.
Joseph L Jilek, Qian-Yu Zhang, Mei-Juan Tu, Pui Yan Ho, Zhijian Duan, Jing-Xin Qiu, Ai-Ming Yu. Mol Ther Nucleic Acids 2019
24
29

Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L Jilek, Zhijian Duan, Qian-Yu Zhang, Ai-Xi Yu, Ai-Ming Yu. Drug Metab Dispos 2018
39
20

The functions of animal microRNAs.
Victor Ambros. Nature 2004
20

Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization.
Wei-Peng Wang, Pui Yan Ho, Qiu-Xia Chen, Balasubrahmanyam Addepalli, Patrick A Limbach, Mei-Mei Li, Wen-Juan Wu, Joseph L Jilek, Jing-Xin Qiu, Hong-Jian Zhang,[...]. J Pharmacol Exp Ther 2015
42
20

RNA therapy: Are we using the right molecules?
Ai-Ming Yu, Chao Jian, Allan H Yu, Mei-Juan Tu. Pharmacol Ther 2019
72
20

Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity.
Mei-Mei Li, Balasubrahmanyam Addepalli, Mei-Juan Tu, Qiu-Xia Chen, Wei-Peng Wang, Patrick A Limbach, Janine M LaSalle, Su Zeng, Min Huang, Ai-Ming Yu. Drug Metab Dispos 2015
39
17

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.
Ai-Ming Yu, Young Hee Choi, Mei-Juan Tu. Pharmacol Rev 2020
74
17

FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
Xin Zhang, Can Hu, Chun-Yan Kong, Peng Song, Hai-Ming Wu, Si-Chi Xu, Yu-Pei Yuan, Wei Deng, Zhen-Guo Ma, Qi-Zhu Tang. Cell Death Differ 2020
144
17

Matrine attenuates pathological cardiac fibrosis via RPS5/p38 in mice.
Xin Zhang, Can Hu, Ning Zhang, Wen-Ying Wei, Ling-Li Li, Hai-Ming Wu, Zhen-Guo Ma, Qi-Zhu Tang. Acta Pharmacol Sin 2021
44
17

Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity.
Xin Zhang, Jin-Xiu Zhu, Zhen-Guo Ma, Hai-Ming Wu, Si-Chi Xu, Peng Song, Chun-Yan Kong, Yu-Pei Yuan, Wei Deng, Qi-Zhu Tang. Int J Biol Sci 2019
61
17

Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway.
Can Hu, Xin Zhang, Wenying Wei, Ning Zhang, Haiming Wu, Zhenguo Ma, Lingli Li, Wei Deng, Qizhu Tang. Acta Pharm Sin B 2019
92
17

Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKα/Smad3 signaling.
Xin Zhang, Zhen-Guo Ma, Yu-Pei Yuan, Si-Chi Xu, Wen-Ying Wei, Peng Song, Chun-Yan Kong, Wei Deng, Qi-Zhu Tang. Cell Death Dis 2018
72
17

Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway.
Can Hu, Xin Zhang, Peng Song, Yu-Pei Yuan, Chun-Yan Kong, Hai-Ming Wu, Si-Chi Xu, Zhen-Guo Ma, Qi-Zhu Tang. Redox Biol 2020
56
17

Novel approaches for efficient  in vivo fermentation production of noncoding RNAs.
Ai-Ming Yu, Neelu Batra, Mei-Juan Tu, Colleen Sweeney. Appl Microbiol Biotechnol 2020
15
33


Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.
David S Hong, Yoon-Koo Kang, Mitesh Borad, Jasgit Sachdev, Samuel Ejadi, Ho Yeong Lim, Andrew J Brenner, Keunchil Park, Jae-Lyun Lee, Tae-You Kim,[...]. Br J Cancer 2020
213
14

Bioengineering of noncoding RNAs for research agents and therapeutics.
Pui Yan Ho, Ai-Ming Yu. Wiley Interdiscip Rev RNA 2016
42
14

Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression.
Xin Li, Ye Tian, Mei-Juan Tu, Pui Yan Ho, Neelu Batra, Ai-Ming Yu. Acta Pharm Sin B 2019
35
14

Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism.
Xin Zhang, Can Hu, Yu-Pei Yuan, Peng Song, Chun-Yan Kong, Hai-Ming Wu, Si-Chi Xu, Zhen-Guo Ma, Qi-Zhu Tang. Cell Biol Toxicol 2021
29
17

Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity.
Can Hu, Xin Zhang, Ning Zhang, Wen-Ying Wei, Ling-Li Li, Zhen-Guo Ma, Qi-Zhu Tang. Clin Transl Med 2020
59
14

Prostate-specific antigen modulates the osteogenic differentiation of MSCs via the cadherin 11-Akt axis.
Longxiang Wu, Shiqi Xiang, Xiheng Hu, Miao Mo, Cheng Zhao, Yi Cai, Shiyu Tong, Huichuan Jiang, Linxiao Chen, Zhi Wang,[...]. Clin Transl Med 2020
10
50

In vivo fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapy.
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Neelu Batra, Michelle M L Tran, Jing-Xin Qiu, Theodore Wun, Primo N Lara, Xiang Hu, Ai-Xi Yu,[...]. Theranostics 2021
8
62


On the origin of cancer cells.
O WARBURG. Science 1956
11

Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.
Yong Zhao, Mei-Juan Tu, Yi-Feng Yu, Wei-Peng Wang, Qiu-Xia Chen, Jing-Xin Qiu, Ai-Xi Yu, Ai-Ming Yu. Biochem Pharmacol 2015
50
11

Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs.
Hannah Petrek, Neelu Batra, Pui Yan Ho, Mei-Juan Tu, Ai-Ming Yu. Appl Microbiol Biotechnol 2019
14
28


The chemical evolution of oligonucleotide therapies of clinical utility.
Anastasia Khvorova, Jonathan K Watts. Nat Biotechnol 2017
496
11

Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models.
Chao Jian, Mei-Juan Tu, Pui Yan Ho, Zhijian Duan, Qianyu Zhang, Jing-Xin Qiu, Ralph W DeVere White, Theodore Wun, Primo N Lara, Kit S Lam,[...]. Oncotarget 2017
20
20

miR-328-3p mediates the anti-tumor effect in osteosarcoma via directly targeting MMP-16.
Jianhui Shi, Gang An, Ying Guan, Tianli Wei, Zhibin Peng, Min Liang, Yansong Wang. Cancer Cell Int 2019
25
16

MiR-328-3p inhibits cell proliferation and metastasis in colorectal cancer by targeting Girdin and inhibiting the PI3K/Akt signaling pathway.
Shuang Pan, Fu Ren, Lei Li, Dahua Liu, Yao Li, Aimei Wang, Weihong Li, Yongyan Dong, Wenjuan Guo. Exp Cell Res 2020
24
16

Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
Bin Xiao, Daxiang Chen, Quan Zhou, Jianfeng Hang, Weiyun Zhang, Zhenzhan Kuang, Zhaohui Sun, Linhai Li. BMC Cancer 2019
17
23

Trichloroethylene-induced downregulation of miR-199b-5p contributes to SET-mediated apoptosis in hepatocytes.
Xiaohu Ren, Zhihong Chen, Jiawen Ruan, Jiacheng Zhong, Rongxia Deng, Wei Liu, Xinfeng Huang, Xifei Yang, Yungang Liu, Jianjun Liu. Cell Biol Toxicol 2019
8
50


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
8

The current state and future directions of RNAi-based therapeutics.
Ryan L Setten, John J Rossi, Si-Ping Han. Nat Rev Drug Discov 2019
492
8


The promise of microRNA replacement therapy.
Andreas G Bader, David Brown, Matthew Winkler. Cancer Res 2010
441
8



Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.
Mehdi Rezaee, Reza Kazemi Oskuee, Hooriyeh Nassirli, Bizhan Malaekeh-Nikouei. J Control Release 2016
109
8

Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo.
Qian-Yu Zhang, Pui Yan Ho, Mei-Juan Tu, Joseph L Jilek, Qiu-Xia Chen, Su Zeng, Ai-Ming Yu. Int J Pharm 2018
25
12



Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran.
Pedro Renato de Paula Brandão, Simoneide S Titze-de-Almeida, Ricardo Titze-de-Almeida. Mol Diagn Ther 2020
41
8

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.